US Patent 12059449 Ophthalmic composition for treatment of dry eye disease
Patent 12059449 was granted and assigned to Novaliq on August, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 14 Aug, 2024
Golden AI
Edits made to:
Infobox (+69 properties)
Article (+303 characters)
US Patent 12059449 Ophthalmic composition for treatment of dry eye disease
Article
Patent abstract
The invention provides ophthalmic compositions comprising about 0.1% (w/v) cyclosporine dissolved in 1-(perfluorobutyl)pentane for use in the topical treatment of dry eye disease and provides for treatment methods thereof. The invention further provides kits comprising such compositions.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Alice Meides0
Chiara Silvana Leo0
Sonja Krösser0
Thomas Schlüter0
Date of Patent
August 13, 2024
0Patent Application Number
177119320
Date Filed
April 1, 2022
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 12059449 Ophthalmic composition for treatment of dry eye disease
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
